Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Vardhman Health Specialities forays into Adult Immunisation
To invest over Rs 100 crores in the division to double its current group revenues of Rs 500 crore in the next two years
NPPA extends ceiling prices of Heparin Injection till Sept 2021
The decision is taken based on the movement in API prices
Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake
Following the news that the European Medicines Agency (EMA) has approved Kixelle, Biocon/Mylan’s biosimilar of Novo Nordisk’s…
Gland Pharma signs deal with RDIF for 252 million Sputnik V vaccine doses
Gland Pharma said it would explore more deals for the vaccine
Ocugen intends to sell 100 million doses of COVAXIN in US in 2021
Cracking the US market would be a significant milestone for the company and India’s vaccine industry
Pharma MSMEs seek government intervention to tackle shortage, price increase of raw materials
Caution that if the situation continues, there could be a scarcity of medicines in the country
Alkem launches anti-epileptic drug BRIVASURE (Brivaracetam)
Brivaracetam has shown promise in patients with epilepsy whose seizures persist despite adequate treatment.
Doctors keen to adopt novel biomarkers for immuno-oncology regimens: GlobalData
The most promising or anticipated biomarker among high-prescribing physicians in the seven major markets was identified to be…
NATCO ventures into Pheromone based tech for Integrated Pest Management
NATCO ventures into pheromone-based tech for integrated pest management
Gilead, Merck sign pact to develop, commercialise long-acting HIV treatment combinations
Collaboration to focus on oral and injectable formulations of Lenacapavir and Islatravir
Strides gets USFDA approval for Potassium Chloride for Oral Solution
Potassium Chloride Oral Solution is indicated for the treatment and prophylaxis of hypokalemia
COVID-19 has created a level playing field for innovators to get their products to market
Ashutosh Mayank and Prajakt Raut, Managing Partners at Supply Chain Labs, Lumis Partners share their insights on new opportunities…
Sun Pharma, Dr Reddy’s, Aurobindo, Jubilant recall products in US
The Indian firms have initiated recall of these products for various reasons including failed impurities/degradation…
CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData
Three leading companies racing to bring CRISPR therapies to the clinic are CRISPR Therapeutics, Intellia Therapeutics and Editas…
Abbott forms Pandemic Defense Coalition
It is a global scientific network dedicated to the early detection of, and rapid response to, future pandemic threats
China continues to lead high value oncology deals in APAC: GlobalData
High-value deals have dominated the Asia-Pacific (APAC) pharma strategic partnership landscape in 2020. Within the region, China…
Hikma, GSK stop talks over potential buyout deal of Egypt, Tunisia assets
Hikma had said in January that it was planning to buy those assets
Parikh family sells stake in ZCL Chemicals to Advent in Rs 2,000 crore deal
The transaction marks one of the largest exits in the API space
AstraZeneca Pharma India gets DCGI approval for Osimertinib tablets
It is now approved as monotherapy for adjuvant treatment after complete tumour resection in patients with NSCLC